Kent Mcdonald, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 243 Curtiss Rd, Barksdale Afb, LA 71110 Phone: 318-456-6600 |
Dr. Kimberly A Loveless, D.O. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 243 Curtiss Rd Ste 100, Barksdale Afb, LA 71110 Phone: 318-456-6600 |
Dr. Jonathan Beich, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 243 Curtiss Road, Suite 100, Barksdale Afb, LA 71110 Phone: 318-456-6555 |
News Archive
Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines, today announced that on July 8, 2010, the Company signed an Acquisition Agreement with Yichun Red Star Forest Bureau of Heilongjiang Province for indefinite exclusive access to 100,000 acres of wild Siberian Ginseng in Heilongjiang Province.
I know how lucky I am to be a patient who happens to also work in the healthcare system. ... Initially, I had to use antibiotic drops every hour. But my insurance would only cover one three-milliliter bottle every three weeks. Each bottle not covered by insurance cost me $130. ... My own experience makes me fear that for many Americans, health insurance may not necessarily equal health care. Access and cost will still remain barriers-;and can be difficult to surmount for many (Dr. Helen Ouyang, 2/24)
A world-first completed clinical study by an Australian team has found Kava, a medicinal South Pacific plant, significantly reduced the symptoms of people suffering anxiety.
Just because scientific advances now allow individuals to learn their genetic make-up doesn't mean they should rush into genetic testing in hopes of making revolutionary improvements to their health, cautions a geneticist and practicing physician at the University of North Carolina at Chapel Hill.
PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced that it has developed several new solutions that take a patient-centric approach to addressing drug development.
› Verified 6 days ago